These charges stem from law enforcement operations targeting pill-mill pharmacies in the Houston area and were unsealed in federal courts across multiple states including Texas, Florida, Missouri and North Carolina, according to an Oct. 3 Department of Justice news release.
Three pharmacy operators from the Houston area were also charged for their involvement. According to court documents, the drugs included potent opioids such as oxycodone, hydrocodone and hydromorphone. The distributors are accused of selling these drugs at inflated prices to customers who would likely sell them on the black market as well as prescription drugs that enhance the opioids.
Principal Deputy Assistant Attorney General Nicole Argentieri emphasized that the defendants allegedly exploited the opioid crisis for profit, resulting in a staggering black-market value of $1.3 billion for drugs involved.
Nine individuals have already pleaded guilty in connection with the case.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
